Trial intelligence / Profile preview

Comparison of PONV incidence for TIVA versus volatile maintenance anesthesia in laparoscopic cholecystectomy or gynecological surgery

TCTR20210312004Phase 3Completed

Sponsor
HRH Princess Maha Chakri Sirindhorn Medical Center
Start
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of propofol + remifentanil in postoperative nausea and vomiting (PONV), sponsored by HRH Princess Maha Chakri Sirindhorn Medical Center. Started Jul 2019; status: completed.

02

Drugs

propofol + remifentanil
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on TCTR20210312004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210312004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call